a Service de neuroradiologie, Hôpital Maison Blanche , Centre Hospitalier Universitaire de Reims , Reims , France.
Expert Rev Med Devices. 2019 Mar;16(3):229-236. doi: 10.1080/17434440.2019.1584035. Epub 2019 Feb 26.
Intrasaccular flow disruption is an innovative technique for the endovascular treatment of intracranial aneurysms. Among flow disrupting devices, the Woven EndoBridge (WEB) is currently the only flow disrupter on the market and has seen an extensive scientific evaluation. It was shown that the device provides a safe and effective treatment particularly for wide-neck aneurysms of proximal bifurcations.
We describe the principal concept and the technical evolution of intrasaccular flow disruption and discuss all devices that have to date been presented, with a special focus on the WEB. Key results of the literature are summarized, and we review possible future indications for this innovative treatment concept.
The tools for the endovascular management of intracranial aneurysms continue to evolve rapidly with intrasaccular flow disruption being the most recent innovation in the field. The WEB is currently the only device on the market. Compared to competing techniques, intrasaccular flow disruption offers several advantages and it is likely that given the technically straightforward nature of the procedure and the high-quality scientific evidence of its safety and efficacy, the device will see a progressive expansion of its indications and will replace standard coiling in an increasing number of cases.
血管内腔内血流阻断是治疗颅内动脉瘤的一种创新技术。在各种血流阻断装置中，编织型腔内隔绝装置（WEB）是目前唯一上市的血流阻断装置，已经进行了广泛的科学评估。研究表明，该装置为宽颈、分叉部近端的动脉瘤提供了一种安全有效的治疗方法。
我们描述了血管内腔内血流阻断的主要概念和技术演变，并讨论了迄今为止已提出的所有装置，特别关注 WEB。总结了文献中的主要结果，并回顾了该创新治疗概念的可能未来适应证。
颅内动脉瘤的血管内治疗工具不断快速发展，血管内腔内血流阻断是该领域的最新创新。WEB 是目前市场上唯一的装置。与竞争技术相比，血管内腔内血流阻断具有多项优势，并且鉴于该技术操作简单，以及其安全性和有效性的高质量科学证据，该装置的适应证可能会逐渐扩大，并将在越来越多的情况下取代标准的线圈栓塞。
